Pacific University FLEXTEND® Study (#3)

FLEXTEND STUDY LINKS
> FLEXTEND STUDIES HOME

> ALLIED HEALTH ASSOC.

> PACIFIC UNIVERSITY #1
> PACIFIC UNIVERSITY #2
> PACIFIC UNIVERSITY #3
> IN-FOCUS CORPORATION
> INDEPENDENT CLINICS
> CLIENT TESTIMONIALS
> CELEBRITY TESTIMONIALS
> MEDICAL REFERENCES

 

ABSTRACT

The Effectiveness of the FLEXTEND ® in the Treatment of Carpal Tunnel Syndrome

Janine M. Boyer, Adam C. Laraway, Gregory S. Milles
Advisors: John Medeiros, PT, PhD and Jay Salzman, PT

Carpal tunnel syndrome (CTS) has been defined as a compression neuropathy of the median nerve at the wrist. Carpal tunnel syndrome, the most common repetitive motion disorder, is on the rise in the United States. As health care costs continue to increase, the need for effective treatment of CTS becomes of paramount importance. Currently, there is no gold standard treatment for CTS that has proven to effectively and consistently treat the symptoms of CTS.

The FLEXTEND ® is a product which proponents claim relieves the signs and symptoms associated with CTS.

STUDY PROTOCOL:

1) Twenty-six hands were randomly divided into either a Control group or FLEXTEND ® Treatment group.

2) Eight hands, already under the care of a physician, were assigned to a Medical Intervention group.

Each hand was measured for the following:

1) Grip strength
2) Visual analog pain scale
3) Phalen's Test
4) Reverse Phalen's Test
5) A Self-Administered Questionnaire for the Assessment of Severity of Symptoms and Functional Status in Carpal Tunnel Syndrome.

The FLEXTEND ® group then received an intervention for four weeks. All groups were retested at four and eight weeks. The results of this study indicated that there was no statistical significance between the groups for grip strength, visual analog pain scale, Phalen's Test, and Reverse Phalen's Test.

View Pacific University Study - FLEXTEND Study Raw Data Information

IMPORTANT FLEXTEND® STUDY SUMMARY INFORMATION:
There was a statistically significant decrease in symptoms and increase in function as measured by the survey between the groups, demonstrating that the FLEXTEND® may be an effective treatment option for CTS.

NOTE: Regarding Grip Strength Levels in FLEXTEND® Users: Studies performed by Pacific University and others utilize a program consisting of only 3-sets of 10 repetitions 2x daily, 3-days per week. This program is suggested for the first week of use only as a "starting program". FLEXTEND® programs are 12-weeks long and are much more aggressive, with clinical and corporate studies showing huge improvements in grip strength.